Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

NASDAQ: INGN

    • Home
    • NASDAQ: INGN
Company Deals Medical Device

Jiangsu Yuyue Partners with Inogen for International Distribution and R&D

Fineline Cube Jan 27, 2025

China-based Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE: 002223) has struck a partnership...

Recent updates

  • Zhaoke BRIMOCHOL-PF Taiwan License Targets Presbyopia Market
  • Kexing GB10 nAMD Injection Secures NMPA Clinical Trial Approval
  • Ignis Therapeutics Cenobamate NMPA Approval Targets Epilepsy
  • Ignis Therapeutics Solriamfetol NMPA Approval Targets OSA Sleepiness
  • Abbisko ABSK043 NSCLC Combo Shows 71% Disease Control at ESMO Asia
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Deals

Zhaoke BRIMOCHOL-PF Taiwan License Targets Presbyopia Market

Company Drug

Kexing GB10 nAMD Injection Secures NMPA Clinical Trial Approval

Company Drug

Ignis Therapeutics Cenobamate NMPA Approval Targets Epilepsy

Company Drug

Ignis Therapeutics Solriamfetol NMPA Approval Targets OSA Sleepiness

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.